Lensar (LNSR) Debt Ratio (2019 - 2026)
Lensar (LNSR) reported Debt Ratio of 0.08 for Q1 2026, down 87.09% quarter-over-quarter from 0.58 in Q4 2019.
Lensar (LNSR) Debt Ratio (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 2 years of Debt Ratio data on file, last reported at 0.08 in Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.08, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.08 (changed N/A YoY), and the FY2019 annual result was 0.58, changed N/A from the prior year.
- Debt Ratio declined to 0.08 in Q1 2026 per LNSR's latest filing, from 0.58 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.08 in Q1 2026 and troughed at 0.08 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.30 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 0.18 |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | 0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.08 |
| Dec 31, 2019 | 0.58 |